Xcopri 150 MG tablet 30S
Ended Awarded
- Contract number
- SPE2DB26FR1QP
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $2,343
Award facts
- Contract value 100% obligated
- $2,343.30 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Xcopri 150 mg tablets (30-count) with a ceiling value of $2,343.30 under a firm fixed-price contract type. The award was issued on October 30, 2025, with an ultimate completion date of October 31, 2025, and represents a non-competitive, non-set-aside procurement. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a total contract value of $999,999,999.00 and extends through December 2026.
Xcopri (cenobamate) is an anticonvulsant medication used in the treatment of seizure disorders. As a child contract under the comprehensive pharmaceutical supply vehicle, this delivery order reflects AmerisourceBergen's critical role as a major pharmaceutical distributor supporting federal military and healthcare systems. The company's DLA contract enables it to supply a broad range of pharmaceutical products and medical supplies to support Defense Health Agency, U.S. Coast Guard, and other government healthcare operations globally. The non-set-aside designation indicates this procurement was awarded through open competition, demonstrating AmerisourceBergen's capability to meet federal pharmaceutical procurement requirements.
Quick answers
Who was awarded contract SPE2DB26FR1QP?
SPE2DB26FR1QP was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on October 30, 2025.
How much is contract SPE2DB26FR1QP worth?
The government has obligated $2,343 on SPE2DB26FR1QP.
Is contract SPE2DB26FR1QP an order under another contract?
Yes. SPE2DB26FR1QP is a delivery order under SPE2DB22D2218, an indefinite delivery contract.
Was contract SPE2DB26FR1QP competed?
The extent of competition for SPE2DB26FR1QP was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award